Search for a clinical trial
Other search option(s)
5 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
GERMANY
Berlin
BERLIN
CSOM230D2203: An open label, multicentre, single arm phase II study of Pasireotide LAR in patients with Rare Tumors of Neuroendocrine Origin - DE
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik für Endokrinologie, Diabetes und Ernährungsmedizin
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin (Phase I-II) - ES (Completed)
Institution: Information not provided - ES
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
An open label, multicenter pasireotide roll over protocol for patients who have completed a previous Novartis sponsored pasireotide study and are judged by the investigator to benefit from continued pasireotide treatment (Phase IV) - ES
Institution: Information not provided - ES
UNITED KINGDOM
Cambridgeshire
CAMBRIDGE
FGFR Study: Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours - UK
University of Cambridge
Department of Medicine
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK